Concepedia

Anat Brafman

AB

Statistics

Publications

6

Citations

996

H-Index

6

Active since

2003

Affiliations

Quark Pharmaceuticals (United States)(Current)

Karolinska University Hospital

Anat Brafman is an author at Quark Pharmaceuticals (United States) specializing in molecular biology, apoptosis, and life sciences.

Publications per year

2003–2011

6

Publications

6

siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury

Bruce A. Molitoris, Pierre C. Dagher, Ruben M. Sandoval et al. · Journal of the American Society of Nephrology · 2009 · 338 citations · Full text

, , +16

Generation of Viable Cholesterol-Free Mice

Andrew S. Wechsler, Anat Brafman, Millicent Shafir et al. · Science · 2003 · 180 citations

, , +2

Ocular neuroprotection by siRNA targeting caspase-2

Zubair Ahmed, Hagar Kalinski, M A Berry et al. · Cell Death and Disease · 2011 · 164 citations · Full text

, , +17

Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1)

Yoshihiko Ohyama, Steve Meaney, Maura Heverin et al. · Journal of Biological Chemistry · 2005 · 139 citations · Full text

, , +13

Inhibition of Oxygen-Induced Retinopathy in RTP801-Deficient Mice

Anat Brafman, Igor Mett, Millicent Shafir et al. · Investigative Ophthalmology & Visual Science · 2004 · 128 citations · Full text

, , +17

1–5 of 6